This study is the result of a collaborative effort between Chile and Mexico, called Salud con Datos that sought to determine GIST prevalence, patients’ clinical characteristics and survival rates. Our report is the largest of its kind in Latin America. The LRG’s Sara Rothschild and Denisse Montoya were the primary point people within the LRG that worked with our partners in Mexico and Chile. Piga Fernández, LRG Global Consultant and Executive Director of Fundacíon GIST Chile was integral as liaison between Fundacíon GIST Chile and Fundacíon GIST Mexico and the LRG.
Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities
Abstract1
Purpose: Like other malignancies, GI stromal tumors (GIST) are highly heterogeneous. This not only applies to histologic features and malignant potential, but also to geographic incidence rates. Several studies have reported GIST incidence and prevalence in Europe and North America. In contrast, GIST incidence rates in South America are largely unknown, and only a few studies have reported GIST prevalence in Latin America. Read details of the study…
Resource:
1Calderillo G, Muñoz-Medel M, Carbajal E, et al. Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities. JCO Glob Oncol. 2020;6:647‐657. doi:10.1200/JGO.19.00410
